Antiviral activity of highly potent siRNAs against echovirus 30 and its receptor

Journal of Virological Methods

Volumn 157, Issue 2, 2009, Pages 211-218

  Rothe, Diana ^a,b   Werk, Denise ^b,c   Niedrig, Sonja ^b   Horbelt, Daniel ^b   Grunert, Hans Peter ^c   Zeichhardt, Heinz ^c   Erdmann, Volker A ^b   Kurreck, Jens ^a,b  

^a UNIVERSITY OF STUTTGART   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Decay accelerating factor; Echovirus 30; RNA interference; siRNA

Indexed keywords

DECAY ACCELERATING FACTOR; RNA POLYMERASE; SMALL INTERFERING RNA;

ANTIVIRAL ACTIVITY; ARTICLE; ASEPTIC MENINGITIS; COMPUTER MODEL; CONTROLLED STUDY; DRUG POTENCY; ECHO VIRUS; EMBRYO; EPIDEMIC; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RNA INTERFERENCE; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE; ENTEROVIRUS B, HUMAN; GENE KNOCKDOWN TECHNIQUES; HUMANS; RECEPTORS, VIRUS; RNA INTERFERENCE; RNA REPLICASE; RNA, SMALL INTERFERING; VIRAL PROTEINS;

HUMAN ECHOVIRUS 30;

EID: 63449122105     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.01.012     Document Type: Article

References (49)

1. Ahn J., Jun E.S., Lee H.S., Yoon S.Y., Kim D., Joo C.H., Kim Y.K., and Lee H. A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J. Virol. 79 (2005) 8620-8624
2. Amarzguioui M., and Prydz H. An algorithm for selection of functional siRNA sequences. Biochem. Biophys. Res. Commun. 316 (2004) 1050-1058
3. Anderson J., and Akkina R. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Ther. 14 (2007) 1287-1297
4. Barnard D.L. Current status of anti-picornavirus therapies. Curr. Pharm. Des. 12 (2006) 1379-1390
5. Bergelson J.M., Chan M., Solomon K.R., St John N.F., Lin H., and Finberg R.W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6245-6248
6. Bergelson J.M., Shepley M.P., Chan B.M., Hemler M.E., and Finberg R.W. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255 (1992) 1718-1720
7. Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., and Finberg R.W. Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J. Virol. 67 (1993) 6847-6852
8. Boden D., Pusch O., Lee F., Tucker L., and Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77 (2003) 11531-11535
9. Brunel D., Leveque N., Jacques J., Renois F., Motte J., and Andreoletti L. Clinical and virological features of an aseptic meningitis outbreak in North-Eastern France, 2005. J. Clin. Virol. 42 (2008) 225-228
10. Cabrerizo M., Echevarria J.E., Gonzalez I., de Miguel T., and Trallero G. Molecular epidemiological study of HEV-B enteroviruses involved in the increase in meningitis cases occurred in Spain during 2006. J. Med. Virol. 80 (2008) 1018-1024
11. Coyne C.B., and Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 (2006) 119-131
12. Dutkiewicz M., Grunert H.P., Zeichhardt H., Lena S.W., Wengel J., and Kurreck J. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3. FEBS Lett. 582 (2008) 3061-3066
13. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
14. Fabani M.M., Turner J.J., and Gait M.J. Oligonucleotide analogs as antiviral agents. Curr. Opin. Mol. Ther. 8 (2006) 108-114
15. Fechner H., Pinkert S., Wang X., Sipo I., Suckau L., Kurreck J., Dorner A., Sollerbrant K., Zeichhardt H., Grunert H.P., Vetter R., Schultheiss H.P., and Poller W. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther. 14 (2007) 960-971
16. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
17. Gitlin L., Stone J.K., and Andino R. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79 (2005) 1027-1035
18. Haasnoot J., Westerhout E.M., and Berkhout B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 25 (2007) 1435-1443
19. Haussecker D. The business of RNAi therapeutics. Hum. Gene Ther. 19 (2008) 451-462
20. Khvorova A., Reynolds A., and Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115 (2003) 209-216
21. Kim D.H., and Rossi J.J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8 (2007) 173-184
22. Kim J.Y., Chung S.K., Hwang H.Y., Kim H., Kim J.H., Nam J.H., and Park S.I. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice. Virus Res. 125 (2007) 9-13
23. Kurreck J. siRNA efficiency: structure or sequence-that is the question. J. Biomed. Biotechnol. 2006 (2006) 83757
24. Lee B.E., and Davies H.D. Aseptic meningitis. Curr. Opin. Infect. Dis. 20 (2007) 272-277
25. Lee H.S., Ahn J., Jee Y., Seo I.S., Jeon E.J., Jeon E.S., Joo C.H., Kim Y.K., and Lee H. Universal and mutation-resistant anti-enteroviral activity: potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region. J. Gen. Virol. 88 (2007) 2003-2012
26. Lu W.W., Hsu Y.Y., Yang J.Y., and Kung S.H. Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem. Biophys. Res. Commun. 325 (2004) 494-499
27. Luo K.Q., and Chang D.C. The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem. Biophys. Res. Commun. 318 (2004) 303-310
28. Merl S., Michaelis C., Jaschke B., Vorpahl M., Seidl S., and Wessely R. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 111 (2005) 1583-1592
29. Merl S., and Wessely R. Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides 17 (2007) 44-53
30. Overhoff M., Alken M., Far R.K., Lemaitre M., Lebleu B., Sczakiel G., and Robbins I. Local RNA target structure influences siRNA efficacy: a systematic global analysis. J. Mol. Biol. 348 (2005) 871-881
31. Patzel V., Rutz S., Dietrich I., Koberle C., Scheffold A., and Kaufmann S.H. Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency. Nat. Biotechnol. 23 (2005) 1440-1444
32. Powell R.M., Schmitt V., Ward T., Goodfellow I., Evans D.J., and Almond J.W. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J. Gen. Virol. 79 (1998) 1707-1713
33. Racaniello V.R. Picornaviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fifth ed. (2007), Lippincott Williams Wilkins, Philadelphia 795-838
34. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8 (2007) 23-36
35. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
36. Saulnier A., Pelletier I., Labadie K., and Colbere-Garapin F. Complete cure of persistent virus infections by antiviral siRNAs. Mol. Ther. 13 (2006) 142-150
37. Schubert S., Grunert H.P., Zeichhardt H., Werk D., Erdmann V.A., and Kurreck J. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs. J. Mol. Biol. 346 (2005) 457-465
38. Schubert S., Grunweller A., Erdmann V.A., and Kurreck J. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J. Mol. Biol. 348 (2005) 883-893
39. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., and Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115 (2003) 199-208
40. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
41. Tan E.L., Tan T.M., Tak Kwong Chow V., and Poh C.L. Inhibition of enterovirus 71 in virus-infected mice by RNA interference. Mol. Ther. 15 (2007) 1931-1938
42. Tseng F.C., Huang H.C., Chi C.Y., Lin T.L., Liu C.C., Jian J.W., Hsu L.C., Wu H.S., Yang J.Y., Chang Y.W., Wang H.C., Hsu Y.W., Su I.J., and Wang J.R. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J. Med. Virol. 79 (2007) 1850-1860
43. Ui-Tei K., Naito Y., Takahashi F., Haraguchi T., Ohki-Hamazaki H., Juni A., Ueda R., and Saigo K. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32 (2004) 936-948
44. von Eije K.J., ter Brake O., and Berkhout B. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82 (2008) 2895-2903
45. Werk D., Schubert S., Lindig V., Grunert H.P., Zeichhardt H., Erdmann V.A., and Kurreck J. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol. Chem. 386 (2005) 857-863
46. Westerhout E.M., and Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res. 35 (2007) 4322-4330
47. Whitton J.L., Cornell C.T., and Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3 (2005) 765-776
48. Yuan J., Cheung P.K., Zhang H.M., Chau D., and Yang D. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J. Virol. 79 (2005) 2151-2159
49. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (2003) 3406-3415